Clinical Trial Update: Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 long-term safety and efficacy evaluation of Lunsekimig in adults with chronic rhinosinusitis with nasal polyps wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Lunsekimig (Lunsekimig)

Snippet

Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Status: RECRUITING